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Abstract: 
Phytochemicals are potential cancer chemopreventive agents, based partly on cellular research establishing that 
phytochemicals inhibit the proliferation of cancer cells. To elucidate the mechanism of phytochemicals, a basic 
understanding is needed of what stimulates cancer cell proliferation. Cancer cells, particularly those that are 
highly invasive or metastatic, may require a certain level of oxidative stress to maintain a balance between 
undergoing either proliferation or apoptosis. They constitutively generate large but tolerable amounts of H2O2 
that apparently function as signaling molecules in the mitogen-activated protein kinase pathway to constantly 
activate redox-sensitive transcription factors and responsive genes that are involved in the survival of cancer 
cells as well as their proliferation. With such a reliance of cancer cells on H2O2, it follows that if the excess 
H2O2 can be scavenged by phenolic phytochemicals having antioxidant activity, the oxidative stress-responsive 
genes can be suppressed and consequently cancer cell proliferation inhibited. On the other hand, phenolic 
phytochemicals and another group of phytochemicals known as isothiocyanates can induce the formation of 
H2O2 to achieve an intolerable level of high oxidative stress in cancer cells. As an early response, the stress 
genes are activated. However, when the critical threshold for cancer cells to cope with the induced oxidative 
stress has been reached, key cellular components such as DNA are damaged irreparably. In conjunction, genes 
involved in initiating cell cycle arrest and/or apoptosis are activated. Therefore, phytochemicals can either 
scavenge the constitutive H2O2 or paradoxically generate additional amounts of H2O2 to inhibit the proliferation 
of cancer cells. 
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Article: 
 
1. INTRODUCTION 
 
Optimum nutrition helps reduce the risk of developing chronic diseases such as cancer. A diet that includes 
plenty of different fruits, vegetables, and other plant products ensures the ingestion of various phytochemicals. 
They include phenolics, which are very large in number and structurally diverse [1], and also glucosinolates, 
which are the precursors to isothiocyanates [2,3]. Although not considered nutrients in the classical sense, 
phenolic phytochemicals and isothiocyanates are bioactive. They have health-promoting properties, especially 
in terms of cancer chemopreventive activity as established by studies with animals where phenolic 
phytochemicals [4] and isothiocyanates [2,3] inhibited tumorigenesis induced by chemical carcinogens. The 
induction of enzymes involved in detoxicating the chemical carcinogens is one primary mechanism to explain 
the antitumorigenic effects of phenolic phytochemicals and isothiocyanates. On the other hand, these two 
distinct classes of phytochemicals may work as cancer chemopreventive agents by preventing a new tumor from 
increasing in size or limiting the proliferation of cancer cells once limited numbers of progenitor cancer cells 
have evolved. 
 
At the cellular level, the molecular effects of phenolic phytochemicals and isothiocyanates in inhibiting the 
proliferation of cancer cells have become clearer over the past few years. To understand how these 
phytochemicals work within the context of this review, a basic understanding is needed of what stimulates 
cancer cell proliferation. Hydrogen peroxide (H2O2) has emerged as a pivotal molecule not only for cancer cell 
proliferation but also in determining the fate of cancer cells exposed to phenolic phytochemicals and 
isothiocyanates. H2O2 either promotes or inhibits the proliferation of cancer cells, and the phytochemicals either 
scavenge or generate H2O2. Drawing from these lines, this review will focus heavily at first on the role of H2O2 
in overactivating signaling processes that subsequently enhance the expression of genes needed for the 
proliferation of cancer cells. Then, the potential of phenolic phytochemicals and isothiocynates to inhibit cancer 
cell proliferation by either decreasing or increasing the levels of H2O2 will be discussed. More specifically, the 
latter part of this review will conceptualize how phenolic phytochemicals and isothiocyanates modulate 
oxidative stress in cancer cells, thereby affecting signal transduction, activation of redox-sensitive transcription 
factors, and expression of specific genes that influence cell proliferation and cell death or apoptosis.  
 
2. CONSTITUTIVE OXIDATIVE STRESS IN CANCER CELLS 
 
Higher amounts of reactive oxygen species (ROS), but particularly hydrogen peroxide (H2O2), are produced in 
some cancer cells. The cumulative production of H2O2 in human melanoma, neuroblastoma, colon carcinoma, 
and ovarian carcinoma cell lines was comparable to that in phorbol ester-stimulated human blood neutrophils 
[5]. This H2O2 production may have reflected initial greater generation of superoxide anion (O2-) either by the 
NADPH:O2 oxidoreductase system or from the mitochondrial electron transport chain, since H2O2 can be 
formed from O2- by the catalytic action of superoxide dismutase. To the contrary [5], the cancer cells appeared 
to lack NADPH:O2 oxidoreductase (cytochrome b559 undetectable), and electron transport inhibitors did not 
prevent the increased production of H2O2. Furthermore, the cancer cells did not produce O2- in stoichiometric 
amounts to account for their higher production of H2O2, which led to the conclusion that the cancer cells 
produced large amounts of H2O2 in a direct manner. However, the exact source or mechanism is unclear. The 
ability of cancer cells to produce large amounts of H2O2 is evident once they evolve as a result of 
transformation, which was demonstrated by a study [6] where compared to parental NIH 3T3 cells, these same 
cells transformed with a Ras oncogene have greater rates of ROS production [6]. 
 
Because cancer cells constitutively produce high amounts of H2O2, the concept of ―persistent oxidative stress in 
cancer‖ originated [7], which provides a plausible explanation for some of the abnormal characteristics of 
cancer cells. For example, compared to their control counterparts, various human tumor tissues contain higher 
levels of 8-hydroxy-2'-deoxyguanosine that is indicative of greater oxidative DNA damage, as previously 
summarized [7] and further corroborated [8]. These findings suggest that the higher amounts of H2O2 increased 
the levels of hydroxyl radical (OH), which can be formed from H2O2 in the presence of metal ions [9]. 
Intracellular iron (Fe
++
) is the metal involved in the oxidative damage to DNA caused by ROS [10]. Therefore, 
additional gene mutations may arise in the cancer cells, further explaining their characteristic genomic 
instability. Other biomolecules are damaged as well. Higher levels of proteins modified by the lipid 
peroxidation product, 4-hydroxy-2-nonenal, and by peroxynitrite (ONOO-), have been detected in carcinoma 
tissue compared to adenoma tissue [8]. 
 
Despite the relatively greater damage to key cellular components such as DNA, cancer cells tolerate the 
damage. That is, they do not undergo cell cycle arrest and/or apoptosis, which is often a consequence of the 
activation of p53 in response to DNA damage [11]. Instead, the cancer cells survive, and they continue to grow 
and proliferate as if the oxidative stress is actually conducive to their vitality. This notion suggests that the 
relatively large amounts of H2O2 being produced by cancer cells have an important role in stimulating cancer 
cell proliferation, rather than the H2O2 merely being a useless and cytotoxic product. 
 
3. POTENTIAL FOR THE HIGHER CONSTITUTIVE H2O2 PRODUCTION IN CANCER CELLS TO 
AUGMENT SIGNAL TRANSDUCTION, GENE ACTIVATION, AND CELLULAR PROLIFERATION 
 
Although originally thought to be a destructive molecule specifically when transformed into hydroxyl radical 
[9], H2O2 is now widely recognized as being extremely important in signal transduction [12]. Hence, it is 
conceivable that the large amounts of H2O2 produced in some cancer cells [5] are needed to mediate signaling 
events that lead to activation of redox-sensitive transcription factors and responsive genes that are involved in 
cancer cell growth, proliferation, and survival. To illustrate this concept, Figure 1 shows how the H2O2 mediates 
signal transduction, leading eventually to the transcriptional activation of some representative genes, namely, 
cyclooxygenase-2 (COX-2), matrix metalloproteinases (MMP), and cyclin B1. In terms of their relevance, 
COX-2 expression is higher in cells from breast cancer tissue [13], colon cancer tissue [14], and cervical cancer 
tissue [15] when compared to cells from normal surrounding tissue. COX-2 protein is involved in the formation 
of prostaglandin E2, an eicosanoid that was recently shown to induce growth factor receptor phosphorylation 
and mitogenic signaling in colon cancer cells [16]. The family of MMP genes code proteins that facilitate tumor 
invasion and metastasis [17]. The cyclin B1 gene codes a protein that allows cell cycle progression through the 
G2/M-phase checkpoint so that mitosis occurs, and is overexpressed in some types of cancer, such as squamous 
cell carcinoma of the esophagus [18]. 
 
In describing the model (Figure 1) more explicitly, known and unknown cellular sources of H2O2 are depicted, 
 
but the largest contributor to the basal or constitutive oxidative stress in cancer cells has not been identified [5]. 
It is likely that a substantial amount of the H2O2 is transformed into ·OH in the presence of metal ions. Perhaps 
by oxidizing key cysteinyl sulfhydryl groups of upstream protein kinases to activate them, or of protein tyrosine 
phosphatases to inactivate them [19], the constant stream of H2O2 or ·OH keeps triggering the signaling events. 
Furthermore, although binding of mitogens such as epidermal growth factor (EGF) to its receptor (EGFR) 
produces H2O2 [20], the large amounts of H2O2 constitutively generated by cancer cells increases protein 
tyrosine kinase (PTK)-mediated phosphorylation or activation of EGFR. Indeed, it is known that H2O2 induces 
phosphorylation of EGFR [21]. This effect on EGFR was inhibited by N-acetylcysteine (NAC), which can 
bolster intracellular levels of glutathione (GSH). Thus, it seems that the thiol redox status may regulate EGFR 
phosphorylation. That is, with oxidation of GSH by H2O2 in cancer cells, the lowered concentrations of GSH 
allow activation of the initial signaling events. Consistent with this notion, oxidative stress that was induced by 
depleting intracellular GSH with N-ethylmaleimide resulted in the accumulation of H2O2 and phosphorylation 
of EGFR [22]. Since catalase and antioxidants prevented these effects, it was concluded that depletion of GSH 
occurred initially, followed by H2O2 accumulation and then EGFR phosphorylation. 
 
Next, according to the model (Figure 1), EGFR activation initiates the Ras signaling cascade that in turn 
activates the MAPK cascade. Thus, the high amounts of H2O2 in cancer cells either directly or through PTK-
EGFR-Ras overactivates MAPK, i.e., one or more of its three family members: extracellular signal-regulated 
kinases (ERK), stress-activated protein kinases (SAPK) that are also referred to as c-Jun N-terminal kinases 
(JNK), and p38 mitogen-activated protein kinases (p38 MAPK). In support of this scheme, exposing pancreatic 
acinar cells to H2O2 activated all three MAPK [23]. The MAPK activation may have been due to depletion of 
GSH because the effects of H2O2 were prevented by NAC. Interestingly, MAPK activation is increased in tumor 
tissue, such as papillary thyroid carcinomas [24], compared to normal adjacent tissue. Because the PTK-Ras-
MAPK sequence of events is active in human tumors, this signaling region is a potential target for cancer 
chemotherapy [25]. 
 
Finally, according to the model (Figure 1), the overactivated MAPK overactivates transcription factors 
including nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1), which are redox-sensitive [26,27]. 
NF-ΚB and AP-1 are required to maintain the phenotype of transformed cells [28,29]. They also are associated 
with the stimulation of cancer cell proliferation. For example, human androgen-independent DU145 prostate 
cancer cells have a higher rate of proliferation than androgen-dependent LNCaP prostate cancer cells [30]. The 
former in contrast to the latter cells expressed activated NF-ΚB and AP-1 constitutively. 
 
Regarding transcription, NF-ΚB can activate cancer-relevant genes, such as the COX-2 gene, that is known to 
have a regulatory DNA sequence in its promoter that binds NF-κB. Consistent with the sequential signaling 
steps, activated JNK, p38 MAPK, and NF-κB have been detected immunohistochemically in human colon 
adenomatous polyps [31]. Cellular localization of the activated NF-κB coincided with that of COX-2. 
Additionally, NF-κB regulated COX-2 gene expression, as well as cellular proliferation, in human gastric 
cancer AGS cells [32]. However, other redox-sensitive transcription factors such as AP-1 can also mediate 
COX- 2 gene expression [33]. 
 
NF-κB is constitutively activated in cancer cells, such as in Hs294T melanoma cells that can be explained partly 
by their expression of a NF-κB-inducing kinase/MAPK pathway [34]. Cancer cells with greater metastatic 
capability have greater NF-κB levels. There is higher constitutive expression of NF-κB in highly invasive 
MDA-MB-231 human breast cancer cells than minimally invasive MCF-7 human breast cancer cells [35]. 
Apparently, NF-κB activity is critical for cancer cell viability. Inhibiting NF-κB in mouse adenocarcinoma 
CSML-100 cells led to apoptosis [36]. 
 
In considering AP-1 (c jun/c-fos) as a transcription factor, it is involved in allowing malignant cancer cells to 
invade and metastasize by activating MMP genes. Various members of the MMP gene family have AP-1 
binding elements in their promoter regions [17], which helps explain why AP-1 via MAPK signaling is 
involved in activating the MMP-9 collagenase gene [37]. Another redox-sensitive transcription of great 
importance is c-myc, a proto-oncoprotein that targets multiple genes including those that stimulate cancer cell 
proliferation [38]. Recently, serial analysis of gene expression (SAGE) revealed that the cell cycle control gene 
cyclin B1, which is overexpressed during carcinogenesis [39], is a direct target of c-myc [40]. 
 
Therefore, according to the overall scheme of events, H2O2 has a pivotal role in functioning as a proliferator of 
cancer cells, whose greater energy metabolism ensures a large continuous supply of H2O2 for this purpose. But, 
can the very molecule that permits cancer cells to thrive also cause their demise? 
 
4. RESPONSE OF CANCER CELLS TO ADDITIONAL OXIDATIVE STRESS 
 
While the constitutive high production of H2O2 in some cancer cells appears to promote their proliferation, 
additional amounts of H2O2 above a certain threshold cause cell cycle arrest and/or apoptosis. Depending on the 
H2O2 concentrations, there are different effects on MAPK activation. Which specific MAPK is activated may 
control the cellular response. When U937 human leukemic cells were exposed to low concentrations of 
exogenous H2O2 (20 µM), there was increased phosphorylation or activation of p38 MAPK that subsequently 
resulted in cell cycle arrest [41]. These effects by H2O2 were prevented by NAC, suggesting that GSH depletion 
triggered the p38 MAPK phosphorylation. JNK was unaffected, and apoptosis did not happen. The p38 MAPK 
activation appeared to prevent apoptosis, since inhibition of p38 MAPK with a specific chemical inhibitor 
permitted the cells to undergo apoptosis. Thus, p38 MAPK activation was needed for survival of the U937 cells 
exposed to relatively low concentrations of exogenous H2O2. In contrast, exposing U937 cells to 1 mM H2O2 
activated JNK and upstream MAPKK that resulted in apoptosis [42]. However, pretreatment of the cells with 50 
µM H2O2, which did not activate JNK, prevented activation of JNK by 1 mM H2O2. Therefore, pretreatment of 
the cells with a low dose of H2O2 blocked activation of JNK induced by a high dose of H2O2. These findings 
suggested that JNK is involved in initiating apoptosis. Consistent with this suggestion, exposing HT-29 colon 
cancer cells to H2O2 led to activation of ERK, JNK, and p38 MAPK and subsequently caused apoptosis [43]. 
But, JNK was involved in triggering the apoptosis since a specific chemical inhibitor of JNK prevented the 
apoptosis. Thus, to what extent the three MAPK are increased by endogenous and/or exogenous H2O2 might 
determine whether cancer cells proliferate, undergo cell cycle arrest, or die by apoptosis. 
 
The persistent oxidative stress in cancer cells apparently sensitizes them to the stress or apoptotic effects of 
anticancer drugs, which often generate ROS. That is, compared to normal cells, cancer cells are more 
susceptible to being killed by anticancer drugs because the cancer cells are already near a threshold for 
tolerating ROS. It is known that NIH 3T3 cells transformed with the Ras oncogene are more sensitive to 
oxidative stress and genotoxins such as cisplatin [6], which was concluded to be due to potentiation of the 
JNK/p38 MAPK pathways. The cis-platin increased ROS production where both mitochondria and NADPH 
oxidases were implicated. Possibly because of similar reasons, cancer cells are more sensitive to killing by 
phytochemicals as will be discussed below. 
 
In reflecting back on the first four sections of this review, H2O2 either stimulates or inhibits the proliferation of 
cancer cells depending on the concentrations of H2O2 present. Accordingly, modulating the concentrations of 
H2O2 in cancer cells could be a means to control their proliferative 
 
activity. How certain phytochemicals modulate the levels of H2O2 to control cancer cell proliferation will be 
considered next as the highlight of this review. 
 
5. SIGNIFICANCE OF ROS IN THE INHIBITION OF CANCER CELL PROLIFERATION BY PHENOLIC 
PHYTOCHEMICALS AND ISOTHIOCYANATES 
 
In theory, the apparent reliance of cancer cells on the basal H2O2-induced oxidative stress for their vitality pro-
vides a logical approach to inhibit their proliferation with antioxidants that scavenge H2O2. That is, if the H2O2 
functions as a secondary messenger in triggering signaling events leading to the activation of cancer cell 
proliferation genes, then scavenging the H2O2 and/or inhibiting protein phosphorylation with phenolic 
phytochemicals having antioxidant activity should short-circuit the signaling events (as Figure 1 lastly shows) 
and eventually inhibit cancer cell proliferation. 
 
On the other hand, it turns out that phytochemicals can paradoxically induce oxidative stress to extents that are 
growth-inhibitory or lethal to cancer cells. From this perspective, Figure 2 conceptualizes how phytochemicals 
such as phenolic phytochemicals and isothiocyanates inhibit cancer cell proliferation by inducing intolerable 
oxidative stress in cancer cells or inducing oxidative stress above and beyond that already present under basal 
conditions. In any event, the intolerable amounts of ROS cause oxidative damage to DNA in conjunction with 
activation of the MAPK cascade and in turn of growth arrest and DNA damage— inducible genes (such as 
GADD45 and GADD153), as well as genes that are involved in initiating cell cycle arrest (such as WAF-1), and 
apoptosis (such as BAX). How phenolic phytochemicals mediate these processes will be considered first, 
followed by what isothiocyanates do. 
 
5.1. How phenolic phytochemicals inhibit cancer cell proliferation 
A recognized property of phenolic phytochemicals is that they have antioxidant activity [1], which is primarily 
attributable to the phenolic hydroxyl groups being able to furnish hydrogen atoms in scavenging ROS. The idea 
has been developed above that H2O2, or the reaction product •OH, is essential for signal transduction and 
activation of specific genes that promote cancer cell proliferation. As such, scavenging these ROS with phenolic 
phytochemicals should inhibit these cellular processes and thus cancer cell proliferation. 
 
Phenolic phytochemicals can inhibit the effects of H2O2 on MAPK signaling events and activation of redox-
sensitive transcription factors, such as NF-κB and AP-1. In some recent examples of studies, the tea phenolic, 
epigallocatechin gallate (EGCG), inhibited MAPK activation that was induced in human epidermal 
keratinocytes by exposing the cells to ultraviolet (UV-B) radiation [44]. The UV-B caused the intracellular 
formation of H2O2 and increased the phosphorylation of ERK, JNK, and p38 MAPK. Because the standard 
antioxidant, ascorbate, also inhibited the effects of UV-B, it was concluded that EGCG inhibited the UV-B-
induced activation of the MAPK by scavenging the H2O2. Resveratrol, a phenolic present at high amounts in 
grapes, prevented NF-κB activation that was induced by tumor necrosis factor (TNF) in U-937 cells, Jurkat 
cells, HeLa cells, and H4 glioma cells [45]. TNF also stimulated the formation of ROS and activation of 
MAPKK and downstream JNK, but these effects were inhibited by resveratrol. Additionally, resveratrol 
prevented NF-κB activation induced by phorbol myristate acetate (PMA), lipopolysaccharide, okadaic acid, 
ceramide, and most importantly, H2O2. 
 
Resveratrol had similar effects on events leading to transcription factor activation, as with the case of AP-1 
[46]. Exposing HeLa cells to either PMA or ultraviolet (UV-C) radiation increased transcription of a reporter 
gene construct containing AP-1 response elements. Pre-treating the cells with resveratrol decreased the 
transcriptional activation of the construct. Reseveratrol pre-treatment also inhibited activation of ERK, JNK, 
p38 MAPK caused by PMA and UV-C. In linking these findings, overexpression of dominant-negative mutants 
of the MAPK in the cells attenuated AP-1 activation induced by PMA and UV-C. The effects of resveratrol 
were suggested to involve inhibition of both protein tyrosine kinases and protein kinase C, because selective 
inhibitors of these enzymes inhibited MAPK and AP-1 activation. 
 
Therefore, such studies [44-46] suggest that phenolic phytochemicals can scavenge the constitutively high 
amounts of H2O2 in cancer cells, thereby blocking MAPK signaling, activation of NF-κB and AP-1, and 
ultimately the expression of responsive genes that stimulate cancer cell proliferation. Because the sustained 
activation of NF-κB and AP-1 in cancer cells maintains a phenotype favoring their proliferation [28,29], 
suppressing the activity of these transcription factors with phenolic phytochemicals would be expected to thwart 
the ability of cancer cells to thrive. 
 
Numerous studies have established that phenolic phytochemicals inhibit the proliferation of cancer cells by 
inducing cell cycle arrest and/or apoptosis, which might be due to scavenging by the phenolic phytochemicals 
of H2O2 or other ROS needed by cancer cells for their vitality or viability. For example, the phenolic 
phytochemical, apigenin, induced growth inhibition of human anaplastic thyroid carcinoma cells that was later 
followed by apoptosis [47]. There was inhibition of EGFR tyrosine autophosphorylation and downstream 
phosphorylation of MAPK. Thus, in exerting its effects, apigenin may have directly inhibited the protein 
phosphorylation, or alternatively, scavenged H2O2 that activates the protein kinases. Resveratrol induced G1- 
phase cell cycle arrest in human epidermoid carcinoma A431 cells [48]. There was decreased protein expression 
of cyclins and cyclin-dependent kinases (CDK) along with reduced CDK activity that normally mediate cell 
cycle progression. Consequently, expression of the CDK inhibitor, p21, increased so that apoptosis was the end 
result. It has been suggested that resveratrol induces apoptosis via JNK activation that leads to phosphorylation 
and hence activation of p53 [49], which is a transcription factor that activates the Waf-1 gene, which codes for 
p21, or the BAX gene, whose translated product is known to promote apoptosis. Other phenolic phytochemicals 
such as quercetin and genistein induced apoptosis in pancreatic carcinoma cells, where mitochondrial 
depolarization, cytochrome c release, and caspase activation were early apoptotic events [50]. Therefore, since 
the phenolic phytochemicals have antioxidant activity, it is logical to think that they induced cell cycle arrest 
and apoptosis in cancer cells by scavenging H2O2, thereby depriving them of an essential molecule needed for 
their existence. 
 
On the other hand, it can be questioned whether phenolic phytochemicals use their antioxidant properties to inhibit the 
proliferation of cancer cells. Although phenolic phytochemicals unequivocally have antioxidant activity [1], 
they can paradoxically have prooxidant activity under certain experimental conditions. That is, some are able to 
generate ROS. EGCG, quercetin, and gallic acid each generated H2O2 in time- and concentration-dependent 
manners when added to cell culture media [51]. Thus, treating cultured cancer cells with these and possibly 
other phenolic phytochemicals can result in substantial extracellular production of H2O2 that can diffuse into the 
cells and cause stressful or cytotoxic effects. Regarding cellular stress, treating MCF-7 human mammary 
carcinoma cells with 15 µM quercetin for 24 hr induced transcriptional activation, via the antioxidant response 
element, of the NAD(P)H:quinone oxidoreductase gene [52], which has an important role in phase II 
detoxification. However, apoptosis occurred in Ha-ras gene-transformed human bronchial epithelial cells after 
being treated with 25 µM of EGCG or related tea catechins for 24 hr [53]. Death of the cells was attributed to 
H2O2 because the catechins induced formation of H2O2 and the apoptosis was prevented by catalase. Consistent 
with the view that H2O2 was involved, the tea catechins decreased c jun protein phosphorylation, which would 
be expected to lower AP-1 activity needed to transcriptionally activate some genes that promote cancer cell 
viability. The apoptosis induced by EGCG in human oral squamous carcinoma cells [54] was also concluded to 
be due to the generation of H2O2 in the cell culture medium. Incidentally, the ability of a non-lethal dose of 
EGCG to increase MAPK-dependent COX-2 gene expression in RAW-264.7 macrophages [55] could be ex-
plained by the formation of additional tolerable amounts of H2O2 by EGCG. 
 
The induction of intolerable amounts of ROS in cancer cells by phenolic phytochemicals initiates apoptosis 
through MAPK activation. This is similar to what has been found with other inducers of apoptosis. For 
example, exposing U-937 promonocytic cells to the toxic heavy metal, cadmium, resulted in the accumulation 
of H2O2 and also phosphorylation of p38 MAPK, followed by apoptosis [56]. Tea catechins including EGCG 
activated MAPK before initiating caspase-mediated apoptosis [57]. Resveratrol induced apoptosis in thyroid 
carcinoma cell lines [58]. There were increases in p53 protein, which was mediated by the Ras/ MAPK 
kinase/MAPK pathway. 
 
The induction of apoptosis in cancer cells by some phenolic phytochemicals such as EGCG may be related to 
oxidative damage to DNA. EGCG [59], as well as curcumin [60], induced single-strand breaks in DNA of 
Jurkat T- lymphocytes. EGCG increased the formation of H2O2 in the cell culture media but curcumin did not 
[60], suggesting that curcumin was taken up by the cells and then induced the formation of ROS intracellularly. 
If such oxidative DNA damage is irreparable, apoptosis would be anticipated. 
 
The capacity of phenolic phytochemicals to generate ROS in amounts sufficient to kill cancer cells raises the 
question whether normal cells are equally susceptible to the prooxidant effects of phenolic phytochemicals. 
Relevant to this question, compared to normal cells, cancer cells are more susceptible to being killed by 
anticancer drugs perhaps because the cancer cells are already near a threshold for tolerating ROS. For example, 
NIH 3T3 cells transformed with the Ras oncogene are more sensitive to both oxidative stress and anti-cancer 
drugs such as cis-platin [6]. Theaflavin monogallates inhibited the growth of Caco-2 colon cancer cells but not 
their normal counterparts [61]. They also induced apoptosis in SV40-transformed WI38 human cells but not 
untransformed WI38 cells. Human oral squamous carcinoma cells and salivary gland tumor cells are more 
susceptible than normal human gingival fibroblasts to apoptosis induced by the phenolic phytochemicals known 
as tannins [62]. 
 
In light of the above, it is unclear whether phenolic phytochemicals inhibit proliferation of cancer cells using 
just their antioxidant power alone or their prooxidant power alone. In contrast, it appears that phytochemicals 
lacking direct antioxidant activity can inhibit cancer cell proliferation by relying just on their prooxidant effects, 
as the case with isothiocyanates discussed below. 
 
5.2. How isothiocyanates inhibit cancer cell proliferation 
In contrast to phenolic phytochemicals, isothiocyanates such as benzyl isothiocyanate (BITC), phenylethyl 
isothiocynate (PEITC), and phenylmethyl isothiocyanate (PMITC) do not have any significant antioxidant 
activity. However, isothiocyanates may inhibit the proliferation of cancer cells in an indirect manner similar to 
the prooxidant action of phenolic phytochemicals. Cultured cells can accumulate high concentrations of some 
isothiocynates, reaching 800- 900 µM after only 30 min of incubation with 5 µM of the isothiocyanates [63]. 
With such a massive isothiocyanate accumulation, cellular effects would be expected. Apparently, a 
stress/defense response is triggered in an effort made by the cancer cells to cope and survive. Phase II 
detoxification enzymes such as NAD(P)H:quinone oxidoreductase are induced by isothiocyanates [64]. 
Additionally, isothiocyanates are substrates for glutathione-S-transferases, which catalyze covalent bonding of 
the sulfur atom of glutathione to the electrophilic central carbon atom of the isothiocyanate group to form 
dithiocarbamate products [65]. It follows that isothiocyanates induce glutathione-S-transferases, which may be 
under redox regulation [66]. Intracellular glutathione levels also become elevated [64] to allow the conjugation 
reaction with the isothiocyanates. Thus, cancer cell proliferation, which may be promoted by low concentrations 
of glutathione as discussed above, would be preferentially arrested in the presence of elevated concentrations of 
glutathione to permit the stressed cancer cells to detoxify the isothiocyanates that threaten their viability. 
 
As was the case for some phenolic phytochemicals described above, isothiocyanates induce oxidative stress in 
cells. Incubating HepG2 hepatoma cells with BITC for 3 hr resulted in a dose-dependent increase in the 
formation of thiobarbituric acid-reactive substances [67], which is a measure of lipid peroxidation caused by 
ROS. Furthermore, the BITC caused DNA damage that was diminished by antioxidants such as α-tocopherol, 
ascorbate, and β-carotene. The effect of BITC on ROS generation has also been reported. The level of ROS 
detected with the fluorescence reagent, 2',7'-dichlorofluorescin diacetate, was about 50-fold higher in BITC-
treated rat liver epithelial RL34 cells compared to untreated cells [66]. 
 
The formation of ROS in cells exposed to isothiocynates would be anticipated to have multiple consequent 
effects. The isothiocyanate known as sulforaphane induced cell cycle arrest in HT-29 human colon cancer cells 
that was associated with increased expression of cyclins A and B1 [68]. A panel of assays determined that 
apoptosis subsequently occurred and in the absence of any change in p53 protein levels. In contrast, 
sulforaphane increased p53 and also the pro-apoptotic protein, Bax, in Jurkat T-lymphocytes [69]. Apparently, 
p53 is not involved in PEITC-induced apoptosis, based on the report that PEITC induced single-strand breaks in 
DNA and subsequent apoptosis in HCT-116 (wild-type p53 gene) and HCT-15 (mutant p53 gene) human colon 
adenocarcinoma cells (see footnote). However, in normal cells, there is an essential role of p53 in PEITC-
induced apoptosis because PEITC induced apoptosis in normal mouse embryo fibroblasts (p53 +/+) but not 
p53-deficient embryo fibroblasts (p53 -/-) [70]. Continuing with the study on the sulforaphane-induced 
apoptosis in HT-29 cells [69], there was increased expression of Bax, which was associated with cytochrome c 
release and cleavage of poly(ADP-ribose)polymerase. These events suggested that caspases were activated to 
execute the cells. Consistent with this thought, PEITC and structural counterparts each induced apoptosis in 
HeLa cervical cancer cells that was linked to caspase-3 activation, since a caspase-3 inhibitor (Ac-DEVD-CHO) 
inhibited the apoptosis [71]. More recent research suggests that generation of ROS and depletion of GSH are 
important in mediating BITC-induced apoptosis that involved caspase-9 activation and the mitochondrial death 
pathway [72]. 
 
Signaling events leading to apoptosis are initiated in cancer cells treated with isothiocyanates. There is ample 
support for a role of JNK in mediating isothiocyanateinduced apoptosis and that a reduction in GSH levels trig-
gers the JNK activation [73]. At 5 µM, PEITC and PMITC each increased JNK activity in human leukemic 
Jurkat T-lymphocytes after 2 hr of incubation. JNK activity remained higher than untreated cells for 12 hr, after 
which chromosomal DNA laddering was observed that is characteristic of caspase-mediated apoptosis. 
Furthermore, using human kidney 293 transformed cells, it was further found that transfecting these cells with 
dominant-negative mutant plasmids of either MEKK or JNK, but not a dominant-negative mutant plasmid of 
p38 MAPK or a wild-type JNK plasmid, suppressed PEITC-induced apoptosis. The signaling events leading to 
apoptosis seemed to be triggered by a decrease in intracellular thiols such as GSH, since two thiol-preserving 
reagents, namely, 2-mercaptoethanol and NAC, inhibited PEITC-induced apoptosis in Jurkat cells. Similarly, 
PEITC and allyl isothiocyanate induced apoptosis that was associated with JNK activation in human leukemic 
HL-60 cells [74]. These effects were prevented by fortifying the cells with GSH before exposing them to the 
isothiocyanates. Therefore, it can be concluded from both of these studies [73,74] that a reduction in the levels 
of intracellular GSH caused by the isothiocyanates allows the critical signaling events leading to apoptosis. 
 
In considering other molecular effects of isothiocyanates, there is cross-signaling that enables the MAPK 
pathway to mediate activation of stress/defense genes that are responsive to oxidative stress, as can be induced 
by isothiocyanates [66,67]. For example, BITC increased reactive oxygen intermediates in association with 
expression of glutathione-S-transferase mRNA and protein [66]. The growth arrest and DNA damage-inducible 
genes (GADD) may also be activated, which typically respond to oxidants that trigger signal transduction. 
Along this line, induction of GADD45 in HCT-116 cells by DNA-damaging UV-radiation involved the MAPK 
pathway [75]. Inhibition of JNK and ERK by expression of a dominant-negative mutant and by a chemical 
inhibitor, respectively, inhibited UV-radiation-induced activation of a GADD45 gene promoter/CAT reporter 
construct. Obviously, transcriptional activation happened because redox-sensitive transcription factors were 
activated. One transcription factor that is activated as a result of DNA damage is OCT-1 [76], which in addition 
to NF-YA and p53, can transcriptionally activate GADD45 [77]. Either thiol-reactive agents or ROS generators 
activated GADD153 gene expression in HeLa cervical cancer cells, which was due to AP-1 activation [78]. 
Therefore, these findings help explain why PEITC increased GADD34, GADD45, and GADD 153 mRNA 
levels in colon adenocarcinoma cells [see previous footnote]. 
 
6. CONCLUSIONS 
 
Some cancer cells constitutively produce high but tolerable amounts of ROS in the form of H2O2, which is 
required for optimum viability. The H2O2 depletes GSH and permits overactivation of protein kinases, that in 
turn overactivate redox-sensitive transcription factors and responsive genes that promote cancer cell survival, 
growth, and proliferation. Phenolic phytochemicals scavenge the H2O2, thereby depriving the cancer cells of an 
essential second messenger. Consequently, cell cycle arrest or apoptosis occurs. On the other hand, exposing 
cancer cells to either phenolic phytochemicals or isothiocyanates can induce the generation of intolerable 
amounts of H2O2, which initiates apoptosis. The effects of phenolic phytochemicals and isothiocyanates on 
cancer cells depend on the dose. It is thought that low concentrations of isothiocyanates and phenolic 
phytochemicals activate MAPK that mediate the expression of defensive and survival genes such as 
glutathione-S-transferases and NAD(P)H:oxidoreductase, whereas higher concentrations of these potential 
cancer chemopreventive substances result in caspase-mediated apoptosis [79,80]. In any event, it is unknown if 
phenolic phytochemicals and isothiocynates kill cancer cells without depending on either their antioxidant or 
prooxidant effects. 
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